RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
The positive allosteric modulator of alpha-2/3-containing γ-aminobutyric acid type A receptors, KRM-II-81, is active in pharmacoresistant models of epilepsy and in human epileptic tissue
Smith, J. L., Ping, X., Jin, X., Golani, L. K., Li, G., Rashid, F., Jahan, R., Cook, J. M., & Witkin, J. M. (2019). The positive allosteric modulator of alpha-2/3-containing γ-aminobutyric acid type A receptors, KRM-II-81, is active in pharmacoresistant models of epilepsy and in human epileptic tissue. Neurosurgery, 66(Supplement_1). https://doi.org/10.1093/neuros/nyz310_697